blog

How Clinical Trial Sponsors Are Responding to COVID-19

By David Fleishman on Fri, Jul 24, 2020 | 7 min read

 

We recently sat down with BBK’s Director of Accounts David Fleishman to discuss his experience working with clinical trial sponsors during the COVID-19 outbreak. It’s clear from our conversation that many clinical trial sponsors have had to quickly pivot in response to COVID-19 and are now facing the challenge of adapting to a new normal.

 

Topics: Patient Engagement, Patient Enrollment, COVID-19, David Fleishman, Virtual

 
Subscribe To Our Blog